References
- Barclay JS , OwensJE , BlackhallLJ. Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen. Support Care Cancer22(7), 1883–1888 (2014).
- van den Beuken-van Everdingen MHJ , HochstenbachLMJ , JoostenEAJ , Tjan-HeijnenVCG , JanssenDJA. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J. Pain Symptom Manage.51(6), 1070–1090; e9 (2016).
- Leap KE , ChenGH , LeeJ , TanKS , MalhotraV. Identifying prevalence of and risk factors for abnormal urine drug tests in cancer pain patients. J. Pain Symptom Manage.62(2), 355–363 (2021).
- Paice JA , BohlkeK , BartonD , CraigDS , El-JawahriA , HershmanDLet al. Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J. Clin. Oncol.41(4), 914–930 (2023).
- Swarm RA , PaiceJA , AnghelescuDLet al. Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology. JNCCN17(8), 977–1007 (2019).
- Schenker Y , HammM , BullsHWet al. This is a different patient population: opioid prescribing challenges for patients with cancer-related pain. JCO Oncol. Pract.17(7), e1030–e1037 (2021).
- Paice JA . Navigating cancer pain management in the midst of the opioid epidemic. Oncology (Williston Park).32(8), 386–390 (2018).
- Carmichael AN , MorganL , DelFabbro E. Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review. Subst. Abuse Rehabil.7, 71–79 (2016).
- Lee B , YangKC , KaminskiP , PengS , OdabasM , GuptaSet al. Substitution of nonpharmacologic therapy with opioid prescribing for pain during the COVID-19 pandemic. JAMA Netw. Open4(12), e2138453 (2021).
- Arthur JA , TangM , LuZet al. Random urine drug testing among patients receiving opioid therapy for cancer pain. Cancer127(6), 968–975 (2021).
- Arthur JA . Urine drug testing in cancer pain management. Oncologist25(2), 99–104 (2020).
- Paice JA , PortenoyR , LacchettiCet al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice guideline. J. Clin. Oncol.34(27), 3325–3345 (2016).
- Dowell D , RaganKR , JonesCM , BaldwinGT , ChouR. CDC clinical practice guideline for prescribing opioids for pain – United States, 2022. MMWR Recomm. Rep.71(3), 1–95 (2022).
- NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain (Version 1.2018). National Comprehensive Cancer Network, PA, USA (2018).
- Starrels JL , BeckerWC , AlfordDP , KapoorA , WilliamsAR , TurnerBJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann. Intern. Med.152(11), 712–720 (2010).
- Childers JW , KingLA , ArnoldRM. Chronic pain and risk factors for opioid misuse in a palliative care clinic. Am. J. Hosp. Palliat. Care32(6), 654–659 (2015).
- Turner JA , SaundersK , ShortreedSMet al. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results. J. Gen. Intern. Med.29(12), 1663–1671 (2014).
- Ahmad AH , ZakariaR. Pain in times of stress. MJMS22, 52–61 (2015).
- Yamakawa Y , NiwaH , IizukaM , FukaiI , KiriyamaM , MasaokaA. Tumor-node-metastasis classification for thymic epitherial tumors. Kyobu Geka46(1), 84–87 (1993).
- Boehnke KF , McAfeeJ , AckermanJM , KrugerDJ. Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic. Int. J. Drug Policy92, 103053 (2021).
- Vidot DC , IslamJY , Camacho-RiveraMet al. The COVID-19 Cannabis Health Study: results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States. J. Addict. Dis.39(1), 26–36 (2021).
- Czeisler MÉ , LaneRI , PetroskyEet al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic – United States, June 24–30, 2020. MMWR69(32), 1049–1057 (2020).
- Yee DA , HughesMM , GuoAYet al. Observation of improved adherence with frequent urine drug testing in patients with pain. J. Opioid Manag.10(2), 111–118 (2014).
- Wainwright JJ , MikreM , WhitleyPet al. Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak. JAMA324(16), 1674–1677 (2020).
- Ochalek TA , CumpstonKL , WillsBK , GalTS , MoellerFG. Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic. JAMA324(16), 1673–1674 (2020).
- Deng G . Integrative medicine therapies for pain management in cancer patients. Cancer J.25(5), 343–348 (2019).
- Salz T , LaveryJA , Lipitz-SnydermanANet al. Trends in opioid use among older survivors of colorectal, lung, and breast cancers. J. Clin. Oncol.37(12), 1001–1011 (2019).
- Bansal V , PingenotE3rd , HuhB , JavedS. Trends of opioid prescription in cancer patients utilizing telemedicine: a retrospective study. Pain Manag.13(9), 509–517 (2023).
- Perez J , NiburskiK , StooplerM , IngelmoP. Telehealth and chronic pain management from rapid adaptation to long-term implementation in pain medicine: a narrative review. Pain Rep.9(6), 1–9 (2021).
- Rigg KK , MonnatSM. Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions. Int. J. Drug Policy26(5), 484–491 (2015).